Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratio

Table 7 Relationship between liver absorbed dose and liver response

		Liver dose (Gy)
Liver response	Patients	Average	Median
No significant LFT change	25	12.4	9.4
Transient LFT abnormalities	7	37.0	23.9
Persistent LFT abnormalities	8	15.2	13.7

ISSN: 1479-5876